When will the FDA approve Compass Pathways' COMP360 Psilocybin?

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Begins in 412 days · Jun 30, 12:00am EDT

$8,569 vol

ALL

Chance

Market Rules

Before July 2027

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes. Sources from U.S. Food and Drug Administration., FDA, and Compass Pathways.

Timeline and payout

Market openMar 24, 2026 · 10:00am EDT

Market closesAfter the outcome occurs

Projected payout30 minutes after closing

This market will close and expire early if the event occurs. Otherwise, it closes by Jun 30, 2027 at 11:59pm EDT.

SeriesKXFDAAPPROVALDATECMPS

EventKXFDAAPPROVALDATECMPS-360

MarketKXFDAAPPROVALDATECMPS-360-27JUL01

Insider trading is prohibited

The following are prohibited from trading this contract:

Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.